Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis

Background Patients with diabetes concomitant to critical limb ischemia (CLI) represent a sub-group at particular risk. Objective of this analysis is to evaluate the actual impact of diabetes on treatment, outcome, and costs in a real-world scenario in Germany.